The distribution of the COVID-19 vaccine has been difficult and time consuming. This is partially because there is a limited supply of vaccines and a much larger demand across the globe. Currently two vaccines have emergency use authorization from the Food and Drug Administration (FDA).  Johnson & Johnson announced on February 4th that they have requested emergency use authorization from the FDA for their COVID-19 vaccine. The FDA is expects to hold their first meeting on the application on February 26.

Johnson & Johnson is the latest company hoping to distribute their vaccine to immobilize the pandemic. Their vaccine is a single dose and is 66% effective overall in preventing moderate to severe COVID-19 four weeks after administering the shot. The vaccine is 85% effective in preventing severe forms of COVID-19. Pfizer’s vaccine is has shown an efficacy of 95% after two doses. The Mode3rna vaccine is 94.1% effective after two doses. Pfizer and Moderna are currently the only companies with emergency use authorization, but with demand exceeding supply it has been difficult to distribute vaccines. The introduction of new vaccine options will help meet demand.

COVID-19 Vaccine Research

While there are currently two vaccines circulating in the United States, multiple companies are working on creating their own COVID-19 vaccine. Many of these vaccines are going through extensive clinical trials, with many trials lasting up to 2 years. National Allergy & ENT Research is currently screening for multiple COVID-19 trials. These trials will provide valuable data to better understand the effects of the different COVID-19 vaccines. This research is crucial for assisting in ending the pandemic. This will allow more vaccines to be approved and help create supply to meet the exceeding demand. Those who are interested can contact the Research department at (843) 261-2222 or sign up for a study online. For those looking for more information on scheduling an appointment for the COVID-19 vaccine here in South Carolina can visit our Vaccine Information page.

 

Source: NPR, World Health Organization